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A B S T R A C T
Despite more attention to cell migration from circulation into the bone marrow (BM), particularly homing of
haematopoietic stem/progenitor cells, the process and mechanisms of cell mobilisation from the BM into the
circulation remain largely underexplored. The process of cell mobilisation or transcellular cell migration from
BM into the circulation (cell egress) is a crucial biological process in mammals as it is important to maintain
homeostasis of various physiological functions including, but not limited to, the immune system, erythropoiesis,
platelet release, and stem cell migration. The BM microvascular system composes of a monolayer of specialized
endothelial cells, called sinusoidal endothelial cells (SECs). While it is very well evident that the process of cell
egress occurs exclusively through BM SECs, there is a lack of systematic analyses addressing the extent of
contribution of BM SECs to the process of cell egress from the BM. Therefore, this review aims to address the
potential ability of BM SECs in regulating and/or facilitating the process of cell egress from BM. In this review,
we address, ﬁrstly, the unique ultra-/structural and molecular features of BM SECs and discuss the possible
biological interactions between BM SECs and various egressing cells in physiological conditions. Secondly, we
propose the potential role of BM SECs in egress of leukemic cells from BM into the circulation. Finally, we discuss
the potential role of BM SECs in homing of haematopoietic stem cells. Collectively, the current review suggests
that the BM SECs may not be merely a neutral gatekeeper for cell intravasation and extravasation, but rather is a
dynamic traﬃcking surveillance system, thereby the process of BM cell egress/mobilisation can be regulated.
1. Background
In mammals, bone marrow (BM) microvascular system possesses
speciﬁc features which distinguish it from microvasculature in other
organs/tissues. The BM microvascular system composes of a monolayer
of specialized endothelial cells, called sinusoidal endothelial cells
(SECs) (Kopp et al., 2005). SECs are also found in other tissues such as
liver (Samson, 2013) and spleen (Huang et al., 2014). By delivering
oxygen, nutrients, cells, and growth factors, the BM microvascular
system plays a substantial role in orchestrating diverse physiological
functions including haematopoiesis, bone formation and bone re-
modelling (Hassanshahi et al., 2018, 2019). Moreover, the BM micro-
vascular system possesses a strong regeneration-enabling potency, for
example for BM haematopoiesis by providing tissue/organ-speciﬁc
“angiocrine factors” (Raﬁi et al., 2016). Furthermore, as illustrated in
mice recently by Itkin et al, cell traﬃcking between BM and circulation
occurs exclusively through BM sinusoidal endothelium (BMSE) (Itkin
et al., 2016). However, although the traﬃcking or egress of mature,
stem, and leukemic cells from BM has been a subject of interest for
many years, less attention has been paid to the role of BMSE in mod-
ulating the process of cell egress from BM. Although several factors
including alterations in cell motility and cell deformation that occur in
egressing cells which may facilitate their egress from BM (Lichtman
et al., 1989), speciﬁc features of BMSE by which the process of cell
egress could be inhibited/facilitated have not been suﬃciently ad-
dressed.
Herein, we attempt to address the questions to what extent BMSE
can aﬀect the process of cell egress in physiological and pathophysio-
logical circumstances, whether BMSE is just a neutral gatekeeper for
cell intravasation and extravasation, or whether it is actually a dynamic
traﬃcking surveillance system. As discussed later, BMSE interacts with
the egressing cells (including involvement of chemotactic factor
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receptors and/or adhesion molecules) in order to facilitate their egress
into the circulation. However, such interactions/contributions might be
speciﬁc for particular cells spatially and temporally. In addition, as it is
also important to address how transplanted haematopoietic stem cells
(HSCs)/progenitor cells (HSPCs) ﬁnd their way home into the BM, this
review will also summarise speciﬁc characteristics of BMSE by which
transplanted HSPCs recognize their home. Furthermore, this review will
discuss roles of BMSE involved in transferring signals and information
between circulation and BM cavity to maintain the homeostasis of cell
traﬃcking and other physiological functions within the bone and BM.
Addressing the above questions has become more important. Since
the BM SECs are the last cells with which egressing cells are directly
and/or indirectly in contact before egressing into the circulation, any
alterations or damage to the BMSE inﬂuence the process of cell mobi-
lization from BM into the circulation. Shedding new lights/insights on
those questions will improve our understanding of the important roles
and involved mechanisms of BM SECs in regulating cell traﬃcking and
can open new avenues for employing better approaches to deal with
mobilization of cells from BM into circulation, thereby providing im-
proved and better treatments.
2. Bone marrow sinusoidal endothelium features for cell egress
2.1. Ultra-/structure of bone marrow sinusoidal endothelium
The BMSE possesses an incomplete basement membrane and has
been known to be devoid of supporting cells such as pericytes (Kopp
et al., 2005). However, recent studies in mice showed that BM capil-
laries (type H capillaries) are surrounded with mesenchymal cells ex-
pressing two markers of pericytes, namely platelet-derived growth
factor (PDGF) receptor β2 and neural/glial antigen 2 (known as NG2) in
the metaphysis (a region of long bone with more trabecular bone and
more active bone remodelling), but not those (type L capillaries) in the
diaphysis (a region with less trabecular bone and less active remodel-
ling) (Itkin et al., 2016). While it has been stated that adventitial cells
reside in the proximity of SECs and cover about 60% of BMSE (Petrides
and Dittmann, 1990), electron microscopy studies by Muto illustrated
that cell egress occurs from those sites in SECs where adventitial cells
are absent (Muto, 1976). Similarly, it was also reported that BM cell
mobilization into the peripheral blood (PB) takes place in regions of
micro-vessels where the adventitial cells are absent and blood-barrier is
solely composed of BMSE (Furze and Rankin, 2008). With this regard,
early studies have shown that adventitial cells are retracted when
egressing cells move towards the BMSE (Becker and De Bruyn, 1976). In
addition, it was suggested that BMSE in mice lacks tight junctions
which govern SECs to interdigitate and slide over each other, which
leads to changes in sinusoidal calibre and thus can facilitate the egress
of cells into the circulation (Tavassoli and Shaklai, 1979). Considering
the ﬁxed volume of marrow in the rigid frame of bone, even rhythmic
calibre changes of BMSE aﬀects the cell egress from BM, and as a result,
cells can be displaced into the lumen of BM sinusoids and subsequently
egress from the BM (Chamberlain and Lichtman, 1978).
Early studies by Chamberlain et al revealed that the process of cell
egress is transcellular and does not occur in random loci, but occurs in
parajunctional zones where the cytoplasm of SECs is attenuated and
thinned (Chamberlain and Lichtman, 1978). Consistently, it was ob-
served that cell egress occurs in regions known as diaphragmatic fe-
nestrae, where the endothelial luminal and abluminal cell membranes
are fused (Campbell, 1972; Levesque et al., 2002). Interestingly, it was
observed that even though SECs are fenestrated, formation of fenestrae
(small pores which are smaller than the sizes of egressing cells) is
transitory and they form at the time of cell egress (Chamberlain and
Lichtman, 1978). Consistent with the report that the sinusoidal wall in
the BM is discontinuous (Inoue and Osmond, 2001), the process of cell
egress from BM appears to occur in BM micro vessels whose basement
membrane is absent and also through the fenestrae which are formed at
the time of cell egress. However, as fenestrae are not pre-existing in BM
SECs, it is worthwhile to investigate whether formation of fenestrae in
BM SECs is a process independent of BM SECs (i.e. merely relying on the
ability of egressing cells to penetrate the BM SEC cytoplasm) or whether
BM SECs also contribute in this process. Although early studies showed
that BM SECs facilitate the egress of cells into the circulation by dis-
charging the contents of lysosomal vesicles in their own cytoplasm,
leading to segmental destabilization and also autolysis of endothelium,
and thus creating a suitable area of cytoplasm for cell egress (Aoki and
Tavassoli, 1981), further mechanistic studies are required to explore the
process of fenestra formation by BM SECs.
2.2. Similarities between bone marrow and hepatic sinusoidal endothelial
cells
In an elegant study by Nolan et al, tissue-speciﬁc molecular sig-
natures of various microvascular endothelial cells were investigated
(Nolan et al., 2013). Transcriptional proﬁling of microvascular en-
dothelial cells revealed that BM SECs have strong similarities with he-
patic SECs. Another similarity of the liver with BM could be the fact that
liver is also a location of haematopoiesis in certain circumstances (Kim,
2010), in where the homing, diﬀerentiation and traﬃcking of HSPCs
are supported by hepatic SECs (Cardier and BarberaGuillem, 1997).
Therefore, for haematopoiesis and egress of haematopoietic cells (HCs),
BM and hepatic SECs have close similarities in terms of expression of
extracellular matrix (ECM) components, chemokines and their re-
ceptors, adhesion molecules, and other factors which are required for
aforementioned purposes. In addition to the similarities of their mole-
cular signatures, BM SECs (Qian et al., 2009) and liver SECs are both
potent scavenger cells and belong to the family of scavenging en-
dothelial cells (Milo et al., 2013; Sorensen et al., 2012). This scavenging
property has been used by McCourt et al as a means to in vivo label and
thereby prospectively isolate functional BM SECs (McCourt et al.,
2015). In addition, similar to BMSE, sinusoids in the liver are also fe-
nestrated, suggesting that the mechanism(s) of fenestra formation in
liver and BM have considerable similarities.
Taken together, considering similarities in physiological, structural
and molecular features of SECs in the liver and in the BM, and the
diﬃculties of isolating and studying BM SECs (Hooper et al., 2009), for
the sake of mechanistic exploration of cell egress from BM, investiga-
tions on hepatic SECs may unravel important insights into the potential
roles of BM SECs in egress of cells from BM.
2.3. Molecular features of bone marrow sinusoidal endothelium and cell
egress
2.3.1. Expression of adhesion molecules and chemokines
BM SECs plays a crucial role in maintenance of cell traﬃcking
homeostasis by providing speciﬁc adhesion molecules, chemoat-
tractants, and others to the mobilizing cells (Table 1). BM SECs possess
a unique feature of constitutive expression of adhesion molecules such
as E-selectin, P-selectin, intercellular adhesion molecule-1 (ICAM-1),
and vascular cell adhesion molecule-1 (VCAM-1) (Furze and Rankin,
2008) (Table 1). Previous studies showed that constitutively expression
of P- selectin, E-selectin, and VCAM-1 by BM SECs are essential for
rolling of HSPCs in BMSE (Mazo et al., 1998). It has been proposed that
some of these adhesion molecules are important for a particular subtype
of cells. For instance, normal HCs bind to VCAM-1; and CD34+ cells
bind to ICAM-1, ICAM-2, and ICAM-3 adhesion molecules expressed in
the microenvironment, mostly by endothelial cells (Bradstock and
Gottlieb, 1995).
Additionally, BM SECs have been reported to express some che-
moattractants which are important for cell egress. BM SECs express C-X-
C motif chemokine ligand 12 (CXCL12) (Burger and Sipkins, 2012), as a
well-known chemoattractant factor, which may aﬀect the process of cell
egress for most HCs (Table 1). Furthermore, mobilization of HSCs into
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the circulation requires cooperation of the signaling of c-kit ligand (eg
stem cell factor or SCF)/c-kit receptor (CD117) (Wozniak and Kopec-
Szlezak, 2004). Interestingly, the expression of c-kit ligand by BM en-
dothelial cells was detected and reported to be important for HSCs
maintenance and expansion (Ding et al., 2012).
Furthermore, it has been also reported that the process of detach-
ment involved in cell egress is mediated by a proteolytic micro-
environment which is induced by proteolytic enzymes produced by
monocytes and granulocytes, as well as administration of granulocyte-
colony stimulating factor (G-CSF) (Levesque et al., 2010) (see below).
Matrix metalloproteinase-9 (MMP-9), for example, has been proposed
to play a key role to regulate normal HC egression from BM (Lane et al.,
2000). While production of MMP-9 by hepatic SECs has been reported
(Yu et al., 2013), further studies will reveal whether BM SECs also
produce MMP-9 and hence have any roles in egress of cells from BM.
Taken together, BM SECs appear to be involved in regulation of cell
egress from BM by providing adhesion molecules, chemokines, and
possibly MMP-9 to the egressing cells.
2.3.2. Extracellular matrix components and other factors
BM SECs also produce important ECM proteins such as collagen type
IV and laminin (Gu et al., 1999; Nilsson et al., 1998; Zuckerman and
Wicha, 1983) by which attachment and detachment of egressing cells
can be modulated (Table 1). In mouse BM, it was found that laminin-10
(α5β1γ1) was the only expressed isoform of laminin which was ex-
pressed by BM SECs, and it was shown that this isoform is potentially
involved in adhesion to BM cells during traﬃcking of the mature blood
cells (Gu et al., 1999). Tenascin-C is another ECM component produced
by BM SECs (Nakamura-Ishizu et al., 2012), which promotes HSC
proliferation (Mendelson and Frenette, 2014). Tenascin-C seems to
possess anti-adhesive features for some cell types, but acts as an ad-
hesive molecule for others such as ﬁbroblasts. However, in the hae-
matopoietic system, it was indicated that various human myeloid cell
lines adhered to tenascin-C (Klein et al., 1993), and it was suggested
that tenascin-C inﬂuences both proliferation and adhesion of devel-
oping HCs (Klein, 1995).
Thrombospondin, another ECM protein in BM microenvironment, is
also produced by BM SECs (Raﬁi et al., 1994), and can act as an ad-
hesion molecule for developing HCs (Klein, 1995). However, when HCs
become mature, their expression of receptors for thrombospondin is
downregulated (Long and Dixit, 1990). In haematopoietic progenitor
cells, thrombospondin together with c-kit ligand and cytokines have
synergistic adhesion functions (Long et al., 1992). Hemonectin, which
is a BM-speciﬁc adhesion protein (Anklesaria et al., 1991), has been
also reported to be expressed by BM endothelial cells (Bradstock and
Gottlieb, 1995), and is found in BM stem cell niche (Campbell et al.,
1987). It was shown that the loss of binding to hemonectin may lead to
egress of mature granulocytes from BM (Campbell et al., 1987). In the
latter study, hemonectin was found to be a lineage-speciﬁc adhesion
molecule for granulocyte lineage cells. In a similar study, Anklesaria
et al found that the adhesion of haematopoietic progenitor cells to the
stromal cells was mediated and inhibited by hemonectin and anti-
hemonectin, respectively (Anklesaria et al., 1991).
Fibronectin is another ECM protein which is expressed by BM ad-
herent cells including endothelial cells (Zuckerman and Wicha, 1983).
Expression of ﬁbronectin has been also detected in human umbilical
vein endothelial cells (HUVECs) (Midulla et al., 2000) and hepatic SECs
(Rieder et al., 1987). HCs also interact with ﬁbronectin in the BM mi-
croenvironment via very late antigen-4 (VLA-4) and VLA-5 on HCs.
Adhesion of ﬁbronectin to VLA-5 has been suggested to negatively af-
fect the haematopoiesis (Klein, 1995).
Within the BM, anti-adhesiveness proteoglycans such as heparan
sulfate proteoglycan perlecan also modulate development of HSPCs
(Klein, 1995). It has been reported that heparan sulfate proteoglycans
are produced by BM stromal cells which are involved in diﬀerentiation
and proliferation of HCs, and maturation of myelomonocytic cell line
Table 1
Bone marrow sinusoid endothelial cell (BM SEC)-derived factors which may inﬂuence the egress process of normal and/or leukemic cells from the bone marrow.
Intercellular adhesion molecule (ICAM); vascular cell adhesion molecule (VCAM); C-X-C motif chemokine ligand (CXCL); von Willebrand Factor (vWF); Roundabout homolog
4 (ROBO4).
Potential factors expressed/provided by BM
SECs
BM egressing cells aﬀected detected in BM SECs and
references:
Adhesion molecules
• E-selectin• P-selectin• ICAM-1• ICAM-2• ICAM-3• VCAM-1
• Basophils, haematopoietic stem/progenitor cells, leukemic cells, acute myeloblastic
leukaemia
• Mast precursor cells, basophils• Haematopoietic stem/progenitor cells, mast precursor cells• Haematopoietic stem/progenitor cells• Haematopoietic stem/progenitor cells• Neutrophils, eosinophils, basophils, mast precursor cells, B lymphocytes, platelets,
leukemic cells, acute myeloblastic leukaemia
• (Furze and Rankin, 2008)• (Furze and Rankin, 2008)• (Furze and Rankin, 2008)• (Bradstock and Gottlieb, 1995)• (Bradstock and Gottlieb, 1995)• (Furze and Rankin, 2008)
ECM components
• Collagen type IV• Laminin• Fibronectin• Sialic acid• Tenascin-C• Thrombospondin• Hemonectin• Hyaluronic acid
• Platelets, leukemic cells, chronic myeloblastic leukaemia• Mast precursor cells, platelets, leukemic cells, acute myeloblastic leukaemia, chronic
myeloblastic leukaemia
• Eosinophils, basophils, mast precursor cells, platelets, leukemic cells, acute myeloblastic
leukaemia, acute lymphoblastic leukaemia
• Eosinophils, basophils, mast precursor cells• Haematopoietic cells• Haematopoietic cells• Neutrophils, eosinophils, basophils• Leukemic cells
• (Nilsson et al., 1998)• (Gu et al., 1999)• (Zuckerman and Wicha, 1983)• (Soda and Tavassoli, 1984)• (Nakamura-Ishizu et al., 2012)• (Raﬁi et al., 1994)• (Bradstock and Gottlieb, 1995)• (Avigdor et al., 2004)
Chemokines
• CXCL12• CXCL1• CXCL2• c-kit ligand
• Neutrophils, basophils, B lymphocytes, platelets, haematopoietic stem/progenitor cells,
leukemic cells, acute myeloblastic leukaemia, acute lymphoblastic leukaemia
• Neutrophils• Neutrophils• Haematopoietic stem/progenitor cells, B lymphocytes
• (Burger and Sipkins, 2012)• (Dimasi et al., 2013)• (Dimasi et al., 2013)• (He et al., 2014)
Glycoproteins
• vWF •
Platelets • (Pusztaszeri et al., 2006)
Other factors
• Low ﬂow velocity• Low shear stress• ROBO4
• Haematopoietic stem/progenitor cells, haematopoietic cells• Haematopoietic stem/progenitor cells, haematopoietic cells• Haematopoietic stem/progenitor cells
• (Bixel et al., 2017)• (Bixel et al., 2017)• (Smith-Berdan et al., 2015)
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HL60 (Klein, 1995). In the liver, hepatic SECs produce perlecan
alongside with collagen IV and laminin, which induces interaction with
integrins of hepatocytes (Rescan et al., 1993). Nevertheless, whether
perlecan is produced by BM SECs and also has any roles in egress of HCs
requires further studies.
Taken together, BMSE provides facilitator molecules (including
adhesion molecules, ECM components, chemokines, glycoproteins and
others) to the egressing cells, thereby allowing the egressing cells to
directly and/or indirectly interact with BMSE and thus egress from BM.
However, it remains to be further explored whether BMSE can govern
expression of cell/lineage speciﬁc molecules spatially and temporally
and thus selectively aﬀect the process of egress of speciﬁc cells from
BM. In the following sections we will address how BMSE might inﬂu-
ence the egress of speciﬁc HCs from BM.
3. Interactions between bone marrow sinusoidal endothelium and
egressing cells in physiological conditions
In early studies, Aoki and Tavassoli proposed that the process of cell
egress from BM depends on the interaction between BM endothelium
and migrating cells (Aoki and Tavassoli, 1981). It has been also stated
that all cells which are produced in BM are thought to enter the cir-
culation through sinusoids (Pereira et al., 2009). Although the main
steps of cell egress from BM are detachment of egressing cells from the
haematopoietic microenvironment, followed by contact and recogni-
tion by BM SECs (Berger et al., 1994), BM SECs, as discussed above,
regulates the egress of HCs from BM by providing required adhesion
molecules, chemokines, and ECM proteins to the egressing cells. In this
section, the potential role of BMSE in facilitating/regulating the egress
of BM HCs from BM in physiological conditions is discussed (Fig. 1).
3.1. Egress of granulocytes from bone marrow
About 1011 neutrophils are mobilized into the PB per day without
aﬀecting the integrity of BMSE (Furze and Rankin, 2008). It has been
stated that the egress of neutrophils from BM is mediated via CXCL12/
C-X-C motif chemokine receptor 4 (CXCR4) axis (Christopher and Link,
2007). Modulation of CXCL12/CXCR4 axis has been proposed to be
potentially used to control neutrophil mobilization (Fig. 1). In addition,
expression of CXCR2 on mature neutrophils was also proposed to fa-
cilitate their egress into the circulation upon binding to CXCL1 and
CXCL2, both expressed by BM endothelial cells (Eash et al., 2010;
Martin et al., 2003) (Fig. 1). CXCR2 and CXCR4 have been demon-
strated to antagonistically regulate neutrophil release from the bone
marrow (Eash et al., 2010). Roles of CXCL12/CXCR4 axis and CXCR2
signalling have also been demonstrated to be important for the function
of G-CSF, which is a very well-known mobilizing factor and used
clinically for mobilizing cells from BM (see below). In a study by
Boettcher et al, it was demonstrated that BM endothelial cells (as the
primary source of G-CSF) translate pathogen signals into G-CSF–driven
emergency granulopoiesis and can facilitate the migration of neu-
trophils from BM (Boettcher et al., 2014). The direct infusion of G-CSF
into the BM vasculature triggered the mobilization of neutrophils se-
lectively (Devi et al., 2013; Wengner et al., 2008) by reducing the ex-
pression of CXCL12 in the BM (Semerad et al., 2005) and CXCR4 on
neutrophils (Sierra et al., 2007), indicating that disruption of CXCL12/
CXCR4 signalling is an important key in G-CSF-induced egress of neu-
trophils from BM (Christopher and Link, 2007). G-CSF promotes ex-
pression of CXCL1 and CXCL2 in BM SECs, and supresses the expression
of CXCR4 and CXCL12 in the BM (Dimasi et al., 2013) by which egress
of neutrophils can be triggered. In mice, the sole receptor for CXCL1
and CXCL2 is CXCR2 (expressed on neutrophils), and signalling via
CXCR2 markedly directs release of neutrophils from BM (Day and Link,
2012). Similarly, administration of exogenous CXCL1 and CXCL2 led to
egress of neutrophils from BM in mice (Delano et al., 2011). In addition,
a crosstalk between CXCR2 and CXCR4 signalling has been also
reported and a substantial role has been suggested from both the
CXCR2 and CXCR4 signalling pathways in egress of neutrophils from
BM (Day and Link, 2012). Therefore, G-CSF induces the egress of
neutrophils from BM via aﬀecting CXCL12/CXCR4 signalling and
probably promoting expression of CXCL1 and CXCL2 by BM endothelial
cells
Another signalling pathway involved in regulating the egress of
neutrophils from BM seems to be via the VLA-4/VCAM-1 axis (Fig. 1). It
was revealed that VLA-4, which is expressed by neutrophils and is re-
quired for egress of neutrophils from BM (Christopher and Link, 2007),
binds to VCAM-1 (an adhesion molecule expressed by BM SECs)
(Issekutz et al., 1996), and that this binding facilitates the egress of
neutrophils into the circulation from BM (Furze and Rankin, 2008).
Conversely, egress of neutrophils was signiﬁcantly reduced following
blockade of VLA-4 (Christopher and Link, 2007). Interestingly, it was
reported that the CXCL12/CXCR4 axis modulates VLA-4/VCAM-1 sig-
nalling pathway and thus regulates retention and egress of neutrophils
from BM (Petty et al., 2009). Collectively, BM SECs appear to play a
crucial role in egress of neutrophils by producing chemokines such as
CXCL12 and CXCL1 and adhesion molecules such as VCAM-1.
BM SECs facilitates the egress of mast cell precursors, basophils, and
eosinophils via providing adhesion molecules, ECM proteins, and che-
mokines. It has now been clear that human eosinophils, basophils, and
mast cells share a number of chemotactic factor receptors and adhesion
molecules (Bochner and Schleimer, 2001). VLA-4, for instance, is ex-
pressed by those three cell types and thus can bind to VCAM-1 and
ﬁbronectin that are expressed by BM SECs (Bochner and Schleimer,
2001), and thus their egress can be facilitated (Fig. 1). Another adhe-
sion structure which eosinophils, basophils, and mast cells have in
common is sialoadhesin family member 2 (known as siglec-8) which
binds to sialic acids (Kikly et al., 2000) and is expressed by BM SECs
(Soda and Tavassoli, 1984). However, how mast cell precursors egress
from BM is still unclear, although it has been reported that rolling on P-
selectin is an important factor for their release (Sriramarao et al., 1996).
In addition, mast cells have been shown to have receptors for ligands
such as ﬁbronectin, laminin, VCAM-1, ICAM-1 (Bochner and Schleimer,
2001) which are expressed by BM SECs. However, it is yet to be in-
vestigated whether and how mast cell precursors exploit these ECM
proteins and adhesion molecules for their mobilization from BM.
Regarding the egress of basophils from BM, it has been reported that
basophils express CXCR4, C-C chemokine receptor 2 (CCR2), P-selectin
glycoprotein ligand (PSGL-1), sialyl Lewis x (CD15 s), and sialyl-di-
meric Lex. These molecules bind to CXCL12, C-C chemokine ligand 2
(CCL2), P-selectin, E- and P- selectins, and E-selectins, respectively,
thereby through which basophil egress can be regulated (Fig. 1).
Freshly isolated eosinophils were shown to have a signiﬁcant pre-
ference for binding to VCAM-1 (Matsumoto et al., 1997). Interestingly,
it was found that eosinophil adhesion and their transendothelial mi-
gration were enhanced following exposure to GM-CSF (Tomioka et al.,
1993) which has been also reported to be produced by hepatic SECs
(Connolly et al., 2010). BM SECs hence might play a crucial role in
egress of eosinophils from BM as they provide various adhesion mole-
cules and chemokines.
Similar to the necessity of sphingosine-1-phosphate (S1P)/S1P re-
ceptor (S1PR) signalling in the egress of T lymphocytes from lymphoid
organs (Cyster and Schwab, 2012), S1P/S1PR signalling also facilitate
the egress of eosinophils from BM, as eosinophils express S1PR on their
surface (Blaho and Hla, 2014). SEW2871 and FTY720, as antagonists of
S1P and S1PR, were shown to inhibit the migration of S1PR1+ eosi-
nophils towards S1P and thus inhibited the migration of eosinophils
from BM to the circulation (Sugita et al., 2010). Furthermore, previous
studies reported the expression of S1P in HUVECs (Ancellin et al.,
2002), lymphatic endothelial cells (Pham et al., 2010), endothelial cells
during organogenesis (Ramasamy et al., 2015) and its receptors in
vascular endothelial cells (Xiong and Hla, 2014). However, investiga-
tions are required to address whether S1P and its receptors are
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expressed by BM SECs, and more importantly whether they aﬀect the
process of cell egress from BM.
Collectively, even though the molecular mechanisms of the above
described molecular interactions between BMSE and egressing cells are
still unclear, it seems that it is through these molecular interactions
between the BMSE and the basophils, eosinophils and mast cell pre-
cursors, that the egress of these cells from BM can be regulated.
3.2. Egress of monocytes from bone marrow
BM SECs might aﬀect the process of monocyte egress from BM by
providing chemokines such as CCL2 and CCL7 (Fig. 1). Monocytes ex-
press high levels of CCR2 whose activation is required for the egress of
monocytes from BM (Jung et al., 2015; Serbina and Pamer, 2006).
Binding of CCL2 (also known as monocyte chemoattractant protein-1
(MCP-1)) to CCR2 is involved in the release of monocytes from BM to
PB (Jung et al., 2015; Serbina and Pamer, 2006). Interestingly, the
production of CCL2 in the proximity of BM vascular sinusoids attracts
monocytes and thus egress of monocytes occurs from BM (Shi and
Pamer, 2011). Interestingly, in a study by Shi et al it was demonstrated
that the lack of CCL2 production by BM endothelial cells signiﬁcantly
reduced monocyte egress from BM into the circulation (Shi et al.,
2011). Furthermore, it was reported that CXCL12/CXCR4 signalling can
upregulate CCL2 in the BM niche and thus CCR2-positive monocytes
would egress from BM via CCL2/CCR2 signalling (Jung et al.,
2015).CCL7 (or MCP-3) is another ligand for CCR2 which was stated to
have a key role for eﬃcient egress of monocytes from BM (Tsou et al.,
2007). However, more investigations are required to address whether
and to what extents BM SECs aﬀect the egress of monocytes from BM.
3.3. Egress of B-lymphocytes from bone marrow
Despite the diversity of BM cell populations, lymphocytes are en-
riched within sinusoids, suggesting that there might be lymphocyte
loading of sinusoids (Pereira et al., 2009). One of the signalling path-
ways which has been debated regarding its role in governing the egress
of B cells from BM is the S1P/S1P receptor signalling pathway. It has
been reported that S1P/S1P receptor signalling is involved in regulating
egress of immature B cells (Pereira et al., 2010). With this regard it was
demonstrated that S1P receptor deletion in mice led to egress of im-
mature B cells from BM (Cinamon et al., 2004). Furthermore, S1P ex-
pressed by platelets, vascular endothelial cells, and erythrocytes attract
B cells from where the S1P concentration is low (Pieper et al., 2013).
Thus, these studies propose that S1P signalling has a role in regulating B
cell egress from BM. However, further studies are required to in-
vestigate whether BM SECs express S1P and whether BMSE-derived S1P
aﬀects the egress of immature B cells from BM.
It has been demonstrated that B cells require CXCR4 and VLA4 for
retention in BM parenchyma. However, while VLA4 is indispensable for
B cell retention in the sinusoids, CXCR4 is dispensable (Cyster and
Schwab, 2012). Studies by Beck et al demonstrated that CXCR4 controls
B lineage cell motility in BM, while developing B cell migration is
strictly dependent on VLA-4/VCAM-1 signalling (Beck et al., 2014).
Furthermore, adhesion of pre- and pro- B cells to CXCL12+ cells was
Fig. 1. Potential regulatory roles of BM SECs in egress of cells from BM into the circulation. BM SECs constitutively provide adhesion molecules such as E-selectin, P-
selectin, ICAM-1, and VCAM-1 to the cells within the BM which have corresponding ligands by which the egress of cells from BM into the circulation might be
facilitated/regulated. Apart from expressing adhesion molecules, BM SECs regulate egress of BM residing cells by providing chemokines including CXCL1, CXCL2,
and CXCL12, and also by providing ECM proteins including collagen IV, laminin, ﬁbronectin, hemonectin, hyaluronic acid, thrombospondin, and tenascin to the
egressing cells. Intercellular adhesion molecule (ICAM); vascular cell adhesion molecule (VCAM); C-X-C motif chemokine ligand (CXCL); C-C chemokine ligand (CCL); C-C
chemokine receptor (CCR); C-X-C motif chemokine receptor (CXCR4); very late antigen-4 (VLA-4); cannabinoid receptor 2 (CB2); Sialoadhesin family member 2 (SAF-2); P-
selectin glycoprotein ligand (PSGL-1); Sphingosine-1-phosphate receptor (S1PR); tyrosine-protein kinase kit (c-kit).
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reported to be mediated via VLA-4/VCAM-1 signalling (Tokoyoda et al.,
2004). In vitro studies showed the migration of CXCR4+ pre- and pro- B
cells towards CXCL12 and it was found that CXCL12 promoted the
proliferation and survival of CXCR4+ pre- and pro- B cells by acting
synergistically with c-kit ligand (Tokoyoda et al., 2004). However, a
recent study by Fistonich et al described molecular mechanisms gov-
erning proB, preB cell adhesion to CXCL12-expressing cells and reten-
tion in BM (Fistonich et al., 2018). This study demonstrated that proB
and IL-7+ cells create a cell circuit regulated by IL-7R signaling, which
regulates CXCR4 and focal adhesion kinase (FAK) expression and con-
trols proB cell movement owing to enhanced adhesion to IL-
7+CXCL12hi cells. In pre B cells, however, this circuit system is dis-
rupted, leading to increased CXCR4 and reduced FAK/α4β1 expression
by preB cells, establishing a fast-moving and lower-adhesion state for
preB cells. Therefore, these studies suggest the important roles of
CXCL12/CXCR4 signalling and VLA-4/VCAM-1 signalling in regulating
B cell development and homeostasis within BM and B cell egress from
BM.
Apart from the potential role of CXCL12/CXCR4 signaling pathway,
cannabinoid receptor 2 (CB2), expressed by B cells (Fig. 1), was pro-
posed to promote VLA-4/VCAM-1-mediated adhesion of B cells to BM
SECs (Pereira et al., 2009). Interestingly, 2-arachydonoyl glycerol
(known as 2-AG), the ligand of CB2 receptor, was reported to be pro-
duced by mouse hepatic SECs (Wojtalla et al., 2011) and human en-
dothelial cells (Sugiura et al., 1998).
Taken together, it seems that CXCL12/CXCR4 and VLA-4/VCAM-1
are two important signalling pathways which may independently or
together impact the egress of immature B cells from BM.
3.4. Contribution of bone marrow sinusoidal endothelial cells to the release
of platelets from megakaryocytes in the bone marrow
Megakaryocytes (MKs) are BM specialised cells that produce plate-
lets (Psaila et al., 2012). Kopp et al showed the positive correlation
between MK numbers and BM sinusoidal microvascular density (Kopp
et al., 2006). This study also stated the dependence of MK development
on properly functional BMSE, since the disruption of vascular re-
modelling resulted in selective loss of MKs. Early studies by Tavassoli
and Aoki showed that MKs are directly in contact with BM sinusoids
(Tavassoli and Aoki, 1981). Mature MKs are located at a close proximity
of abluminal surface of sinusoids where they extend transendothelial
pseudopods to produce platelets.
Furthermore, MKs have been shown to be attracted to the BMSE in
response to ﬁbroblast growth factor 4 (FGF-4) and CXCL12 (Avecilla
et al., 2004). FGF-4 promotes adhesion of MKs to VCAM-1 (expressed
on BM SECs), via upregulation of VLA-4 on the surface of MKs (Johns
and Christopher, 2012) (Fig. 1). Chemoattractant CXCL12, also pro-
duced abundantly by BM SECs, is known to attract MKs.
Moreover, compared to other endothelial cells such as HUVECs, BM
SECs are more specialised in regard to supporting MK diﬀerentiation
(Raﬁi et al., 1995). BM SECs supports MK diﬀerentiation possibly via
secretion of the thrombopoietic cytokines interleukin-6 (IL-6) and c-kit
ligand (Raﬁi et al., 1997). Direct contact of CD34+ cells and en-
dothelium showed greater numbers of CD34+ cells diﬀerentiating into
MK progenitors (Raﬁi et al., 1995).
BM SECs aﬀects the fate of MKs and their release of platelets by
regulating the production of ECM proteins for MKs. While some early
studies observed that the distribution of collagen type IV and laminin,
two ECM proteins produced by SECs, is absent at the MK/SEC interface
(Hamada et al., 1998), some other studies showed that collagen type IV,
which is produced by SECs (Table 1), supports proplatelet formation
(Nilsson et al., 1998; Pallotta et al., 2009). Glycoprotein Ib (GpIb),
which is deﬁcient in patients with Bernard-Soulier syndrome, contains
binding sites for adhesion for plasma glycoprotein von Willebrand
Factor. Since von Willebrand Factor is expressed on endothelial cells,
GpIb presence is crucial for adhesion of platelets to the endothelium
(Geddis and Kaushansky, 2004), proposing its importance in supporting
platelet formation. Consistently, in vitro studies showed that antibodies
against GPIb signiﬁcantly inhibited the formation of proplatelets
(Balduini et al., 2011; Takahashi et al., 1999).
Furthermore, ﬁbronectins, which are abundant in BM vascular niche
and also expressed by SECs, have a potential role in platelet release.
Studies showed that VLA-4 and VLA-5, activated by ﬁbronectins, con-
tribute to the formation of proplatelets via increased activation of ex-
tracellular signal–regulated kinase 1/2 (Erk1/2) (Matsunaga et al.,
2012). In addition, other necessary factors for platelet release could also
include mechanical forces and blood ﬂow-induced hydrodynamic stress
which shear oﬀ fragments of megakaryocyte protrusions, resulting in
platelet release into the circulation (Kacena et al., 2006; Wang et al.,
1998). Consistently, ﬂuid shear forces in sinusoids were demonstrated
to support the intravascular release of fragments protruding from MKs
(Dunois-Larde et al., 2009; Junt et al., 2007).
Collectively, based on the stronger preference of MKs to interact
with BM SECs than other types of endothelial cells, and also considering
the involvement of BMSE in the MK development by providing che-
moattractants, adhesion molecules, and ECM proteins to MKs, BMSE
plays a key role in release of platelets from BM.
3.5. Egress of reticulocytes from bone marrow
Reticulocytes are immature red blood cells which are developed
within the BM and then egress into the circulation to eventually give
rise to mature red blood cells (Ah-Moye et al., 2014). In order to pro-
liferate and diﬀerentiate within the BM, erythroblasts are located
within erythroblastic islands which are composed of erythropoietic
progenitor cells attached to a central macrophage (Wang et al., 2013).
Previous studies have demonstrated that the erythroblastic islands ad-
jacent to the BM sinusoids contain mature erythroblasts, while im-
mature erythroblasts are populated away from the BM sinusoids in the
erythroblastic islands (Yokoyama et al., 2003). In order to egress into
the circulation, mature reticulocytes require to detach from the central
macrophages and migrate into the circulation through BMSE (Manwani
and Bieker, 2008). In addition, early studies showed that reticulocytes
undergo signiﬁcant deformation to pass through the BM sinusoidal
pores which are made at the time of cell egress (Lichtman and Santillo,
1986).
Several studies showed that BMSE can contribute signiﬁcantly in
proper egress of reticulocytes from BM. It has been shown that the at-
tenuation of BM SECs cytoplasm occurs at the site of cell egress, facil-
itating the egress of reticulocytes from BM (Lichtman and Santillo,
1986). Furthermore, the egress of reticulocytes through the BM sinu-
soidal endothelial pores needs higher pressure in the direction of the
sinusoids (Yokoyama et al., 2003), and pre-existing pressure across the
sinusoidal membrane drives the reticulocytes to egress through the si-
nusoidal pores (Lichtman and Santillo, 1986). Pioneering studies on the
process of reticulocytes egress from BM revealed that BMSE undergo
several alterations by which the egress of reticulocytes are facilitated/
regulated (Chamberlain and Lichtman, 1978). Of such, at the time of
red cell egress through BM SECs, BM SECs slide over each other in re-
sponse to the luminal pressure, and subsequently sinusoids become
dilated, leading to increase of the BM sinusoidal surface area and
thinning the BM SECs, which facilitate the egress of mature re-
ticulocytes into the circulation. In addition, the presence of vesicles
containing a ﬂocculant substance in the BMSE at the time of re-
ticulocyte egress suggested that these vesicles are lysosomes and create
areas of cytoplasm suitable for cell migration by i) autolysis of the
endothelium, and ii) discharging their contents into the cytoplasm and
causing segmental destabilization in BM SECs (Chamberlain and
Lichtman, 1978). Another mechanism by which BM SECs can aﬀect the
mobilisation of reticulocytes from BM is the ability of BMSE to regulate
their cell surface positive/negative charge. It has been demonstrated
that BMSE reduce the expression of cell surface sialic acids by which the
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negative charge of BM SEC cell surface is reduced (Soda and Tavassoli,
1984). This phenomenon leads to the attraction and mobilisation of
mature reticulocytes which have negative cell surface charge toward
the BMSE and permits cell-cell interaction between reticulocytes and
BM SECs and eventually egress of reticulocytes from BM (Soda and
Tavassoli, 1984). Therefore, by undergoing signiﬁcant physical altera-
tions/adaptation, BMSE can regulate/facilitate the egress of re-
ticulocytes from BM.
The molecular interactions between mature reticulocytes and BM
SECs have not been suﬃciently explored. However, it has been widely
reported that reticulocytes express a wide range of adhesion molecules
including α4β1 and ICAM-4, which interact with corresponding re-
ceptors of VCAM-1 and αv, respectively, expressed by central macro-
phages within the erythroblastic islands near the BM sinusoids
(Manwani and Bieker, 2008). It is known that VCAM-1 and αv receptors
are expressed by endothelial cells and thus it may be speculated that
reticulocytes can communicate with BM SECs via their surface adhesion
molecules. It should be noted that αv heterodimerizes with β3 to form
αvβ3 integrin which has been detected in BM endothelial cells
(Vandoorne et al., 2018). Moreover, BMSE-derived ECM proteins can
regulate the migration of mature reticulocytes from BM. It has been
stated that the aﬃnity of maturing reticulocytes (via α4β1 and α5β1)
for ﬁbronectin reduces with maturation (Telen, 2000), which can lead
to their passing through the matrix around the sinusoids and egress
(Chasis and Mohandas, 2008). However, unlike ﬁbronectin, the pre-
sence of laminin, particularly laminin 10/11, which are present in the
subendothelial basement membrane of bone marrow sinusoids (Gu
et al., 1999), can function to localize reticulocytes to the BM sinusoids
(which is considered as an initial step of reticulocytes egress into the
peripheral circulation) (Chasis and Mohandas, 2008). Therefore, the
BMSE can regulate/facilitate the egress of reticulocytes into the circu-
lation by providing an appropriate physical transendothelial route and
by providing an appropriate extracellular matrix environment to the
reticulocytes.
3.6. Bone marrow sinusoidal endothelium and egress of haematopoietic
stem/ progenitor cells from bone marrow
Apart from the potential roles of BMSE in controlling egress of
mature and also more specialised cells from BM, BMSE also potentially
contributes/regulates the egress of HSPCs from BM. Hypothetically, the
mechanism of egress of HSCs or HSPCs from BM might be somewhat
similar to the process of their homing into the BM (discussed later). In
this section we aim to address the potency of BMSE-derived chemoat-
tractants, adhesion molecules and other potential factors which might
directly and/or indirectly inﬂuence migration of HSPCs from BM
(Fig. 1).
3.6.1. CXCL12/CXCR4 and VLA-4/VCAM-1
BM endothelial cells have been reported to facilitate the diapedeses
of stem cells more than endothelial cells of other organs (Imai et al.,
1999). HSPCs are anchored to their niche in the BM due to interactions
of CXCL12 and VCAM-1, provided by niche, with their corresponding
receptors CXCR4 and VLA-4 expressed on HSPCs (Levesque et al., 2010)
(Fig. 1). Treatment with AMD3100 (an antagonist for CXCR4 and a
rapid stem cell mobilizer) was demonstrated to induce cytokine c-kit
ligand abundance preferentially on BM SECs, and cause rapid HSPC
mobilization from BM via shedding and releasing of CXCL12 and c-kit
ligand from BM (Itkin et al., 2016). In the steady state in mice, CXCL12-
derived from BM stromal cells was shown to be a pivotal factor for the
egress of haematopoietic progenitor cells from BM, but not for egress of
mature leukocytes (Dar et al., 2011). It should be noted that the extent,
temporal and spatial patterns and mechanisms for the activation of the
CXCL12/CXCR4 signalling pathway may vary in diﬀerent HCs for mo-
bilisation into the circulation. For instance, Petit et al. demonstrated
that administration of G-CSF (a widely used BM cell mobiliser that
interferes with CXCL12/CXCR4 axis) led to gradual reduction of
CXCL12 levels but an increase in CXCR4 expression within the human
and murine BM, which resulted in egress of HSCs from BM (Petit et al.,
2002). Similarly, in a study by Katayama et al, decreased CXCL12 ex-
pression was demonstrated in bone following G-CSF therapy in mice,
which negatively aﬀected the egress of haematopoietic stem cells from
BM (Katayama et al., 2006). In contrast, exogenously elevation of
CXCL12 resulted in increases in numbers of HCs with repopulating
capacity, progenitor cells, and precursor cells (Hattori et al., 2001).
Taken together, the temporal and spatial changes in CXCL12 and/or
CXCR4 expression determine the role and the extent of importance of
the CXCL12/CXCR4 signalling for haematopoietic (stem-) cell egress
from BM.
CXCL12 can also trigger activation of CD44 (receptor for hyaluronic
acid) on HSCs which binds to hyaluronic acid (expressed by BM en-
dothelium (Avigdor et al., 2004)) and functions as a ligand for E-se-
lectin, and L-selectin (Schroeder and DiPersio, 2012). Exposure of
CD34+ cells to CXCL12 has been reported to increase the aﬃnity of
VLA-4 to VCAM-1 (Sison and Brown, 2011). Interestingly, the homing
of HSCs in adult spleen and BM was prevented by inhibition of VCAM-1,
CD44, and VLA-4 (Papayannopoulou et al., 1995; Vermeulen et al.,
1998; Williams et al., 1991). In humans, mobilization of HSCs following
disruption of VLA-4/VCAM-1 axis has been evident (Zohren et al.,
2008). In the BM niche, SECs also express E-selectin (Yin and Li, 2006)
and soluble factors like c-kit ligand which binds to c-kit (expressed on
HSCs) and promotes HSC growth and proliferation (Brandt et al., 1992),
suggesting a key role of BM SECs in haematopoiesis and possibly for
HSPC migration from BM.
3.6.2. Adhesion molecules
Adhesion molecules such as ICAM-1, ICAM-2, VCAM-1, L-selectin,
and E-selectin have been suggested to be involved in egress of stem cells
from BM. The loss of CAMs and acquisition of membrane structure fa-
cilitate normal egress of cells from BM (Cavenagh et al., 1994). In ad-
dition, it was reported that the egress of CD34+ progenitor cells from
BM was due to selectin-mediated adhesive interactions with BM en-
dothelium (Cavenagh et al., 1994). However, further studies are re-
quired to elaborate the role of such adhesion molecules and their in-
volvement in egress of HSCs from BM to PB.
3.6.3. G-CSF- and chemotherapy- induced HSC egress and vascular
integrity
The exact mechanisms by which HSCs egress from BM following G-
SCF therapy or in combination with chemotherapy are still unclear
(Szmigielska-Kaplon et al., 2014). It should be taken into consideration
that chemotherapy agents and/or G-CSF inﬂuences the physiology of
BM sinusoids (Hassanshahi et al., 2017), resulting in the egress of HSCs
from BM. For example, in mice, it was observed that mobilization of
HSCs from BM following G-SCF administration was associated with
reduced expression of VCAM-1 in BM endothelial cells (Salvucci et al.,
2012). Apart from the role of G-CSF in egress of HSCs from BM, che-
motherapy can also aﬀect the process of HSC egress from BM. It was
reported that the high dose chemotherapy in animal models and pa-
tients induced BM niche damage, leading to failure of stem cell mobi-
lization to BM, following transplantation (Bendall and Bradstock,
2014). In another similar study, the high-dose chemotherapy damaged
the sinusoidal endothelium of BM and thus altered the interaction be-
tween BM SECs and CD34+ cells and their ability to mobilize these
cells into the circulation (Liesveld et al., 1994). It was also shown that
reducing the loss of endothelial cells in the BM niche following neu-
rotoxic chemotherapy would signiﬁcantly overcome failure of the au-
tologous donor mobilization and thus enhance regeneration of the
haematopoiesis (Lucas et al., 2013). Therefore, it seems that alteration
of the physiology/function of BMSE could be one of the mechanisms
involved in G-CSF and chemotherapy-induced HSC egress from BM.
Collectively, as revealed from investigations into the mechanism
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how BM retains HSPCs and how chemotherapeutic- and mobilising
agents induces the egress of HSPCs from BM, the egress of HSPCs from
BM might be obtained through perturbing VLA-4/VCAM-1 and CXCL-
12/CXCR4 signalling axes within the BM.
4. The role of bone marrow sinusoidal endothelium in egress of
leukemic cells
Some early studies had investigated whether BMSE impacts egress
of cells in pathological conditions, with some reporting that BMSE may
not impact the egress of cells in a pathological conditions (Bruyn et al.,
1977), and others stating that the egress of cells in a pathological state
might be due to breakdown or alterations in marrow-blood barrier
(Chen et al., 1972). Despite these early controversial reports, more re-
cent studies, as discussed below, have shown that BMSE does aﬀect cell
egress in pathological conditions through its altered physiology. It was
reported that patients with acute leukaemia and preleukemia diseases,
such as myeloproliferative neoplasms, myelodysplastic syndromes, had
higher levels of angiogenesis and vascularization in BM (Ayala et al.,
2009). In addition, enhanced angiogenesis as induced by leukemic cells
increase survival of leukaemia cells in the BM (Mirshahi et al., 2009;
Perez-Atayde et al., 1997) and potentially can aﬀect the egress of leu-
kemic cells from BM. Moreover, while under normal conditions the
passage of myeloid blood cells from BM into the circulation is restricted
to mature forms of the cells, in the abnormal conditions such as in AML,
the selectivity in the egress of myeloid cells into the PB is disturbed, and
thus many immature cells appear in the circulation (Bruyn et al., 1977).
Since one of the major obstacles in leukaemia treatment now is ex-
cessive egress of leukemic cells from BM and invasion into the various
tissues/organs, studying the potential role of BMSE in egress of leu-
kemic cells is important.
4.1. Altered ECM components of bone marrow sinusoidal endothelial cells
by leukemic cells
In an early study, Berger et al examined interactions between leu-
kaemia blast cells with ECM proteins such as laminin, collagen type IV,
and ﬁbronectin which are produced by BM SECs, and observed an in-
verse correlation between binding of blasts cells to ECM (Berger et al.,
1994). This study concluded that the ability of cells to egress into the PB
depends on the degree of cell binding to the ECM of haematopoietic
microenvironment (Berger et al., 1994). It has been also stated that
malignant B cells interact with the ﬁbronectin and HA of ECM of BM
niche via VLA-4 and CD44, respectively (Burger and Sipkins, 2012). In
both acute myeloblastic leukaemia (AML) and acute lymphoblastic
leukaemia (ALL) cells, β1 and to the lesser extent β2 integrins were
shown to be important for interactions with cellular and extracellular
microenvironment in BM (Bendall et al., 1993). Studies have proposed
that such interactions between the leukemic cells and ECM components
are important for acute leukemic cell behaviour and remission fol-
lowing chemotherapy (Bradstock and Gottlieb, 1995). BM endothelial
cells produce a wide range of matrix components such as hemonectin,
sialoadhesion, thrombospondin, and tenascin, which are likely to be
involved in adhesion of both normal haematopoietic and leukemic cells
(Bradstock and Gottlieb, 1995). In leukaemia, it has been stated that the
BM stem cell niche, where the endothelial cells are in close proximity
with stem/progenitor cells, is hijacked by leukaemia cells (Schroeder
and DiPersio, 2012). In addition, it was observed that the adherence of
CD34+ leukemic cells to the HUVECs was due to an increase in ex-
pression of E-selectin, but not VCAM-1, in HUVECs (Liesveld et al.,
1994). Therefore, while further studies are required to conﬁrm this, it
might be speculated that the expression of ECM components by BM
SECs can be modulated by leukaemia cells as they need to migrate from
BM.
AML blasts, similar to normal HSCs, express a variety of adhesion
molecules such as CD44, VLA-4, CD117, and receptors such as CXCR-4,
which mediate the interactions of AML blasts with BM stromal cells,
promote survival and proliferation of both cell types (Nervi et al.,
2009). Alterations in molecular expression and thus adhesive pheno-
types of AML cells facilitates their egress from BM to the circulation, as
well as governing proliferative advantages in the BM (Cavenagh et al.,
1994). Consistently, early studies showed that AML blast cells adhere to
human ECs via selectin- and VCAM-1-mediated adhesive interactions
(Cavenagh et al., 1994). Among AML cells, some adhere to ﬁbronectin
and laminin in their microenvironments via β-integrin VLA-4, VLA-5,
and VLA-6 (Kortlepel et al., 1993). In addition, CD31 (also known as
PECAM-1) was expressed in all cases of AML cells, which could bind to
the BM endothelium (Bradstock and Gottlieb, 1995). AML cells can also
bind to the endothelium by interactions of VLA-4 and sialylated Lewis X
on AML cells with VCAM-1 and E-selectin of endothelium, respectively
(Cavenagh et al., 1993).
In the case of CML, CML progenitors do not adhere to ﬁbronectin
nor BM stroma; but they adhere to collagen IV and laminin, whereas
normal progenitors do not (Verfaillie et al., 1992). Consistently, it was
suggested that one of the potential reasons of early egress of morpho-
logically mature CML granulocytes from BM is due to lowered adhesion
of ﬁbronectin in those cells (Vijayan et al., 1994). Similarly, CML
granulocytes showed a considerably decreased binding to P-selectin,
when compared to normal cells, which might implicate the early egress
of those cells from BM (Vijayan et al., 1997).
Since such interactions confers cell adhesion-mediated drug re-
sistance by which the malignant cells become resistant to che-
motherapy (Nervi et al., 2009), understanding the interactions between
leukemic cells with their niche, particularly with BM SECs, may provide
better treatments for those diseases. It might be worthwhile to speculate
that AML/CML cells manipulate the proper function of BM SECs in
order to provide ECM proteins to the cancer cells by which their egress
can be facilitated.
4.2. Altered expression of proteolytic enzymes and leukemic cell egress
Another feature of leukemic cells by which their egress could be
facilitated is their ability to produce gelatinase that degrades collagen
type IV, which is the major component of basement membrane pro-
duced by BM SECs (Van Agtmael and Bruckner-Tuderman, 2010). In
addition, elastase, which is normally produced by neutrophils (Yang
et al., 2016), was illustrated to increase expression of E-selectin on
endothelial cells, and thus facilitating the motility and dissemination of
cancer cells (Nozawa et al., 2000). It was also found that elastase de-
grades VCAM-1, ICAM-1, P-selectin, CXCL12, and c-kit ligand (Lapidot
and Petit, 2002) and facilitates the process of transendothelial migra-
tion (Ginzberg et al., 2001).
In AML cells, the expression of elastase was found to be regulated by
CXCL12, and inhibition of elastase activities impaired homing of human
AML cells in the BM (Tavor et al., 2005). Interestingly, the proliferation
of human AML cells was also shown to be elastase-dependant (Tavor
et al., 2005). The latter study showed that the inhibition of elastase
reduced the adhesion of AML cells to the BM endothelial cells, and
concluded that proliferation and egress of AML cells from BM are
regulated by cell surface elastase which is CXCL12-dependant. More-
over, elastase, like other proteolytic enzymes such as MMPs, is involved
in the process of G-CSF-induced mobilization of stem/progenitor and
mature cells (Tavor et al., 2005). As mentioned above, neutrophils and
monocytes pave the way for egress of other cells from BM; and there-
fore, it might be postulated that neutrophils can also pave the way for
egress of leukemic cells from BM by (over) expression of elastase,
thereby expression of BM SEC-derived adhesion molecules and che-
mokines required for leukemic cell egress can be regulated.
A study by Song et al found that the increased invasiveness and the
acquired drug resistance feature of human AML cells were obtained via
upregulation of MMP-2 (Song et al., 2009). Consistently, MMPs, parti-
cularly MMP-2 and MMP-9 were reported to be important for migration
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of human AML cells (Hatﬁeld et al., 2010). While CXCL12 signalling
can be altered by MMPs, CXCL12 induces secretion of MMP-9 and
MMP-2 in CD34+ cells (McQuibban et al., 2001). As Hartﬁeld states,
CXCL12, along with MMP-2 and MMP-9, might function as a regulator
for AML cell egress (Hatﬁeld et al., 2010). Therefore, BMSE-derived
CXCL12 might contribute to the egress of AML cells via promotion of
MMPs in the egressing cells.
Collectively, the cellular behaviour/functions of BMSE can be al-
tered during pathological circumstances such as haematological ma-
lignancies. The BMSE manipulated by leukaemia cells thus provides
factors required for their egress from BM. Therefore, it makes BMSE a
good target for further investigations into the strategies to inhibit mi-
gration of leukaemia cells from BM.
4.3. Potential roles of CXCL12/CXCR4 and VLA-4/VCAM-1 signalling
pathways in egress of leukaemia cells from bone marrow
Moreover, production of CXCL12 and IGF-1 (also expressed by he-
patic ECs (Zimmermann et al., 2000)) by BM stromal cells was shown to
increase in patients with acute leukaemia (Mirshahi et al., 2009), and
CXCR4 has been found to be commonly expressed by a variety of leu-
kaemia cells (both myeloid and lymphoid) (Mohle et al., 2000). In
addition, CXCL12/CXCR4 signalling pathway has been found to in-
crease the aﬃnity of VLA-4 to VCAM-1 (Burger and Sipkins, 2012).
Thus, CXCL12 has been implicated to be a very important element in
promoting adhesion of malignant cells to the blood vessels in the BM
(Sipkins et al., 2005), and CXCL12/CXCR4 axis has been shown to have
a substantial role in egress of leukemic cells from BM. Furthermore, as
CXCL12, provided in BM niche, would confer proliferation and survival
of leukemic cells, targeting CXCL12/CXCR4 axis might overcome the
resistance of leukemic cells to chemotherapy (Sison and Brown, 2011).
Interestingly, targeting CXCL12/CXCR4 axis has been reported both
preclinically and clinically to be an eﬀective approach to treat AML,
ALL, chronic myeloblastic leukaemia (CML), and chronic lymphoblastic
leukaemia (CLL) diseases (Sison and Brown, 2011).
VLA-4 integrins also cooperate with the chemokine receptors of
malignant B cells, including multiple myeloma, CLL, and mantle cell
lymphoma to adhere to the BM stromal cells (Burger and Sipkins,
2012). Leukaemia cell lines and primary AML blasts were shown to
express VLA-4 consistently (Sison and Brown, 2011), and it has been
suggested that VLA-4 is a prognostic indicator of paediatric AML
(Walter et al., 2010) and CLL (Burger and Sipkins, 2012). Consistently,
it was also revealed that adhesion of leukaemia cells to stromal cells
was interrupted by targeting either VCAM-1 or VLA-4 (Liesveld et al.,
1993). Similarly, Spiegel et al showed that treatment of precursor-B
ALL cells with VLA-4 antibodies resulted in considerably less homing of
the cells in the BM (Spiegel et al., 2004). It should be noted that VLA-4/
VCAM-1 adhesion pathway may be similarly important as the CXCL12/
CXCR4 axis pathway, as both are important for egress of haemato-
poietic (stem-) cells and leukemic cells. However, while this VLA4/
VCAM1 adhesion pathway is involved in the regulation of mobilisation
of haematopoietic (stem-) cells in a physiological condition, it is dys-
regulated in a pathological condition such as leukemia (probably by
leukemic cells).
In T-cell acute lymphoblastic leukaemia (T-ALL), leukaemia in-
itiating cells, which are believed to be responsible for relapse following
chemotherapy, reside within BM niches, which are composed of
CXCL12-produing SECs and perivascular cells (Sugiyama and
Nagasawa, 2015). Pitt et al demonstrated that T-ALL cells are directly in
contact with CXCL12-producing BM stroma. This study further showed
that BMSE-derived CXCL12 impeded tumor growth, while the ad-
ventitial cells-derived CXCL12 was dispensable (Pitt et al., 2015), which
may imply the importance of BMSE-derived factor for survival and
proliferation of leukemic cells. This study suggests that targeting
CXCL12/CXCR4 signalling could be a robust therapeutic approach for
this devastating cancer (Pitt et al., 2015). BMSE might also have a role
in development of B-ALL as adhesion of pre-B lymphoid cells to their
microenvironments is facilitated by their binding to ﬁbronectin via
VLA-4 and VLA-5 expressed by ALL cells (Makrynikola and Bradstock,
1993). Thus, potential interactions between BMSE (by providing re-
quired chemoattractants and ECM proteins) and ALL cells might be
necessary for ALL cells to egress from BM. However, whether BM SECs
are inﬂuenced by ALL cells to provide necessary egressing factors re-
mains a mystery and thus warrants further studies.
Therefore, similar to the potential of CXCL12/CXCR4 and VLA-4/
VCAM-1 signalling pathways for egress of mature and HSPCs from BM,
aforementioned signalling pathways can also be important for migra-
tion of leukaemia cells from BM, and targeting the VLA-4/VCAM-1 axis,
alone or in combination with targeting CXCL12/CXCR4 signalling
pathway, may provide better approaches to manage the egress of leu-
kemic cells into the circulation.
5. The role of bone marrow sinusoidal endothelium in
haematopoietic stem cell homing and engraftment
Apart from the roles of BMSE in retaining and regulating pro-
liferation, diﬀerentiation, and egress of HSCs, BMSE can also be in-
volved in facilitating homing of HSCs (Asri et al., 2016). Due to the
importance of the biological process and the signiﬁcance of BM/HSC
transplantation in clinical practice, it is crucial to investigate the cel-
lular and molecular mechanisms underlying the homing of the circu-
lating HSCs into the BM. With this regard, pioneering studies demon-
strated the importance of BM microvascular system (by providing
required adhesion molecules and chemokines) in homing of HSPCs into
the BM (Frenette et al., 1998; Hidalgo et al., 2002; Mazo et al., 2002;
Mazo and von Andrian, 1999). It could be hypothesized that the process
of HSCs homing into the BM is somewhat similar to the process of HSC
egress from BM into the circulation via coordination between chemo-
kines, selectins, and integrins which has been reported to be necessary
for homing of HSCs into the BM (Asri et al., 2016). Hypothetically, it
might be even very similar to the process of transendothelial migration
of inﬂammatory cells into the injury sites, in which a complex but
regulated interaction between circulating inﬂammatory cells and en-
dothelial cells exist. Therefore, considering the unique molecular fea-
tures of BMSE, herein we address the potential role of BMSE in facil-
itating the homing of HSCs into the BM and also in the success of BM
transplantation.
5.1. The role of bone marrow sinusoidal endothelium in homing of HSCs
into the bone marrow
BMSE plays a crucial role in facilitating the initial steps of HSC
homing (Perlin et al., 2017b). BMSE not only directs HSCs to the BM,
but also functions as a molecular brake and aﬀects the process of mi-
gration of HSCs into the BM by slowing the process of cell homing
under hemodynamic shear stress (Sackstein, 2016).
The homing of HSCs occurs via rolling and ﬁrm adhesion of HSCs to
the BMSE and transendothelial migration of HSCs across the en-
dothelium/ECM barrier and subsequent anchoring of HSCs to their
niche (Mosaad, 2014). The coordinative interactions between mole-
cules expressed by BMSE including E- and P-selectin, VCAM-1, ICAM-1,
ICAM-2, ICAM-3, and CXCL12 with corresponding molecules of HSCs
results in homing of HSCs into the BM (Mosaad, 2014) (Fig. 1). PSGL-1,
CXCR4, and type 1 receptor for S1P are the most important receptors
involved in HSPC homing into the BM (Xia et al., 2004) (Fig. 1). Con-
stitutively expression of P-selectin by BM SECs can interact with mucin,
known as PSGL-1, expressed on HSPCs, resulting in homing of HSPCs
(Xia et al., 2004). Loss of function studies demonstrated that the
homing of HSCs was signiﬁcantly impaired due to E- and P-selectin
deﬁciency (Frenette et al., 1996; Mazo and von Andrian, 1999;
Schweitzer et al., 1996). In addition, studies by Adamiak et al revealed
that expression of S1P within the BM plays a substantial role in homing
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of HSPCs, and also suggested the potential role of HA and CD44 in-
teractions for HSPC homing (Adamiak et al., 2015). Moreover, the
rolling of HSCs to the BMSE has been reported to be mediated via ex-
pression of E- and P- selectins on BM SECs. Following rolling, expres-
sion of ICAM-1 and VCAM-1 adhesion molecules by BM SECs then is
promoted, by which further ﬁrm attachment of HSCs to the endothelial
cells is in turn granted (Suarez-Alvarez et al., 2012). Interestingly, HSCs
express corresponding molecules to ICAM-1 and VCAM-1, called func-
tion-associated antigen 1 (LFA-1) and VLA-4, respectively. Therefore,
by providing adhesion molecules to the HSPCs, BM SECs can interact
with HSPCs and facilitate/regulate their homing into the BM.
Recent studies in zebraﬁsh revealed that niche-derived CXCL8/
CXCR1 signaling increases HSPC niche colonization via remodelling the
vascular caudal haematopoietic tissue niche (Blaser et al., 2017). CXCR
1 and its ligand CXCL8 are expressed in endothelial cells in caudal
haematopoietic tissue of zebraﬁsh, and this CXCL8/CXCR1 axis mod-
ulates the HSPC retaining and the number of cell divisions in the vas-
cular niche in the BM (Perlin et al., 2017a). Interestingly, enhanced
expression of CXCL12 leads to the increased volume of the vascular
niche, and through this mechanism CXCR1 increases the HSPC niche
engraftment (Blaser et al., 2017). Moreover, expression of CXCL12 can
enhance attachment of LFA-1 and VLA-4 to their corresponding en-
dothelial ligands (Suarez-Alvarez et al., 2012). After rolling and at-
tachment, degradation of basement membrane is then facilitated by
expression of MMPs; and following extravasation, retention of HSCs is
provided by expression of CXCL12 in the niche (Suarez-Alvarez et al.,
2012). Similar to its role in retaining and in enabling rapid mobilization
of HSCs into the circulation, the importance of CXCL12/CXCR4 axis in
homing of HSCs into the BM has been reviewed previously (Georgiou
et al., 2010) (Fig. 1).
Modifying the levels of expression and functions of molecules in-
volved in BM homing has been reported to increase the rate of HSCs
homing. This strategy can enhance the expression of cell surface re-
ceptors and/or increasing the biological adhesiveness function of HSCs
(Ratajczak and Suszynska, 2016). Apart from the role of adhesion
molecules in homing of HSCs, reduced BM sinusoidal ﬂow velocities
and low shear stress were also found two key elements of BMSE that
facilitate homing of HSPCs into the BM (Bixel et al., 2017). Also, in an
elegant study by Smith-burden it was demonstrated that Roundabout
homolog 4 (known as ROBO4) protein, expressed by BM SECs, is ne-
cessary for homing of HSCs, but is dispensable for egress of HSCs from.
In all steps mentioned above, BMSE potentially can play a crucial role
in regulating/facilitating the homing of HSCs into the BM. Therefore,
BMSE seems to be an important part for the homing and also engraft-
ment of HSPCs by providing ROBO4, CXCL12, HA, S1P, adhesion mo-
lecules, ﬁne-tuned ﬂow velocities, and sheer stress.
5.2. Bone marrow sinusoidal endothelium and the success of haematopoietic
cell transplantation
As a potentially curative therapeutic approach, haematopoietic cell
transplantation (HCT) is conducted for treatment of various non-ma-
lignant and malignant haematopoietic diseases. The success of HCT
mainly depends on the engraftment of HSCs and reconstitution of
haematopoiesis. The conditioning regimen, i.e. chemo-radiotherapy, is
an essential component of autologous and allogenic HCT and is usually
conducted in order to reduce the tumour burden, and provide adequate
immunoablation to prevent graft rejection (Gyurkocza and Sandmaier,
2014). Since chemo-radiotherapy can damage BMSE which could aﬀect
the process of HSPC homing and engraftment, it is very important to
consider or anticipate the chemo-radiotherapy-induced BMSE damage
(Hassanshahi et al., 2017). As many studies revealed, radiotherapy
(Hooper et al., 2009; Slayton et al., 2007) and chemotherapy caused
BMSE damage (Hassanshahi et al., 2017, 2019; Kopp et al., 2005) and
as a consequence, reconstitution of haematopoiesis can be aﬀected.
Chemotherapy and irradiation can also alter the ﬁne-tuned level of BM
oxygenation, resulting in negative eﬀects on the process of cell traf-
ﬁcking (Spencer et al., 2014). Apart from delivery of oxygen by BMSE
into the BM, BMSE provides paracrine growth factors, called “angio-
crine factors” (Raﬁi et al., 2016), by which regeneration and replen-
ishment of HSPC population are supported following myeloablation
(Kobayashi et al., 2010). Interestingly, as a novel therapeutic approach,
ex vivo co-culture of HSCs and endothelial cells not only showed im-
proved expansion of mouse and human HSPCs ex vivo, but also in-
creased long-term multi-lineage engraftment and re-constitution of
HSPCs in vivo (Butler et al., 2012, 2010; Gori et al., 2017; Hadland
et al., 2015; Kobayashi et al., 2010; Poulos et al., 2015). Taken to-
gether, BMSE not only inﬂuences the HSPC retention, proliferation,
diﬀerentiation and mobilization, but also maintains the homeostasis of
haematopoiesis by facilitating the homing and engraftment of HSCs.
Conversely, any damages to BMSE leads to imbalance of various phy-
siological processes including cell traﬃcking and haematopoiesis.
6. Conclusions
BMSE is biologically very well structured and suited for rapid cell
traﬃcking within the BM. It is now clear that BMSE has an important
role in regulating cell egress from, and homing into, the BM in phy-
siological and pathophysiological conditions. BMSE provides a wide
variety of factors/molecules such as cytokines (including chemokines),
adhesion molecules, and ECM proteins, which facilitate/regulate the
cell egress or homing temporally and spatially. BMSE also plays a
crucial role in homing and engraftment of transplanted HSPCs within
the BM. In addition, it seems that the egress of leukemic cells from BM
is facilitated due to remarkably altered ECM components of BM SECs by
leukemic cells and interaction of BMSE with leukemic cells via
CXCL12/CXCR4 and VLA-4/VCAM-1 signalling pathways. Therefore,
the current review suggests that the BMSE is not merely a neutral
gatekeeper for cell intravasation and extravasation, but rather is a dy-
namic traﬃcking surveillance system, thereby the process of BM cell
egress can be regulated/facilitated. However, more investigations are
required to elaborate the regulatory role of BMSE in the process of cell
traﬃcking in physiological and pathological conditions.
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